Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Brought to you by:
ophthalmology
Brought to you by:
Biotech
Italian biotech raises $141M series B to fund eye gene therapies
AAVantgarde Bio has raised $143 million in series B funds that the Italian biotech will use to push its two gene therapies through the clinic.
James Waldron
Nov 3, 2025 3:00am
Science's retinal implant restores some vision in AMD patients
Oct 21, 2025 6:50am
I-Mab unveils new name, strategy, asset and Hong Kong IPO plans
Oct 17, 2025 10:45am
AviadoBio secures option to rare eye disease gene therapy
Oct 9, 2025 8:50am
Eye disease biotech launches with $100M, Roche rival in clinic
Sep 17, 2025 6:30am
Iantrek sees $42M fundraising for alternative glaucoma surgery
Aug 20, 2025 11:50am